Neuronetics Launches Major Registry To Track NeuroStar TMS Outcomes

02 Dec 2016

The registry will collect data from more than 6,000 depression patients treated with transcranial magnetic stimulation at more than 100 different treatment facilities in the US to better understand how the therapy benefits patients in the "real world."

A new major registry will collect outcomes data on the Neuronetics Inc.NeuroStar transcranial magnetic stimulation (TMS) to understand how the therapy for depression is being applied in US clinics in the United States.

"TMS is an effective treatment for patients who are not responding to our typical approaches to depression," psychiatrist Kenneth Pages,...